Contact Us
Discovery of antagonist MAbs against the GPCR CB1 for treating NASH
Read More
ACTNov 15th-18thSan Antonio, Texas
PEGS EuropeNov 17th-19thLisbon, Portugal
Antibody Engineering & TherapeuticsDec 13th-16thSan Diego, CA